EMA reviewing safety of Uptravi for pulmonary arterial hypertension (updated)*

View source ↗

Summary

EMA is reviewing safety information for Uptravi (tracleer? actually Uptravi is selexipag) in pulmonary arterial hypertension and providing updates as new data e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Uptravi (selexipag)